SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000059478-20-000155
Filing Date
2020-10-28
Accepted
2020-10-28 10:57:01
Documents
74
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lly-20200930.htm   iXBRL 10-Q 2859686
2 EX-18.1 lly-9302020xxex181eyprefer.htm EX-18.1 5699
3 EX-31.1 lly-9302020x10qxexhibit311.htm EX-31.1 13384
4 EX-31.2 lly-9302020x10qxexhibi.htm EX-31.2 13401
5 EX-32 lly-9302020x10qxexhibit32.htm EX-32 11319
  Complete submission text file 0000059478-20-000155.txt   12007348

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20200930.xsd EX-101.SCH 51900
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lly-20200930_cal.xml EX-101.CAL 89723
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20200930_def.xml EX-101.DEF 299869
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20200930_lab.xml EX-101.LAB 652004
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20200930_pre.xml EX-101.PRE 424469
11 EXTRACTED XBRL INSTANCE DOCUMENT lly-20200930_htm.xml XML 3078296
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06351 | Film No.: 201266838
SIC: 2834 Pharmaceutical Preparations